Gene · 5934
Papers3,186
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,186
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5. | J Alzheimers Dis | 2024 | 38160360 | PubTator, text mining | PubMed |
| Phospholipase PLCE1 Promotes Transcription and Phosphorylation of MCM7 to Drive Tumor Progression in Esophageal Cancer. | Cancer Res | 2024 | 38117512 | PubTator, text mining | PubMed |
| Considerations for enhanced mesenchymal stromal/stem cell myogenic commitment in vitro. | Clin Transl Sci | 2024 | 38098144 | PubTator, text mining | PubMed |
| Molecular mechanism governing RNA-binding property of mammalian TRIM71 protein. | Sci Bull (Beijing) | 2024 | 38036331 | PubTator, text mining | PubMed |
| Identified senescence endotypes in aged cartilage are reflected in the blood metabolome. | Geroscience | 2024 | 37962736 | PubTator, text mining | PubMed |
| ORAOV1, CCND1, and MIR548K Are the Driver Oncogenes of the 11q13 Amplicon in Squamous Cell Carcinoma. | Mol Cancer Res | 2024 | 37930255 | PubTator, text mining | PubMed |
| Molecular classification of small cell lung cancer subtypes: Characteristics, prognostic factors, and clinical translation. | Chin Med J (Engl) | 2024 | 37660289 | PubTator, text mining | PubMed |
| Correlating somatic copy number alteration in aqueous humour cfDNA with chemotherapy history, eye salvage and pathological features in retinoblastoma. | Br J Ophthalmol | 2024 | 36931696 | PubTator, text mining | PubMed |
| Prevalence of IgG antibodies against Malawi polyomavirus in patients with autoimmune diseases and lymphoproliferative disorders subjected to bone marrow transplantation. | Front Immunol | 2023 | 38299147 | PubTator, text mining | PubMed |
| Molecular and Genetic Advances in Small Cell Lung Cancer Landscape: From Homogeneity to Diversity. | Int J Mol Sci | 2023 | 38203395 | PubTator, text mining | PubMed |
| Actionable Driver Events in Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 38203275 | PubTator, text mining | PubMed |
| The Follow-Up Necessity in Human Papilloma Virus-Positive vs. Human Papilloma Virus-Negative Oral Mucosal Lesions: A Retrospective Study. | J Clin Med | 2023 | 38202065 | PubTator, text mining | PubMed |
| Single-cell immunophenotyping revealed the association of CD4+ central and CD4+ effector memory T cells linking exacerbating chronic obstructive pulmonary disease and NSCLC. | Front Immunol | 2023 | 38187374 | PubTator, text mining | PubMed |
| Recent Progress in CDK4/6 Inhibitors and PROTACs. | Molecules | 2023 | 38138549 | PubTator, text mining | PubMed |
| Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis. | Pathogens | 2023 | 38133265 | PubTator, text mining | PubMed |
| Methods on improvements of the poor oral bioavailability of ginsenosides: Pre-processing, structural modification, drug combination, and micro- or nano- delivery system. | J Ginseng Res | 2023 | 38107396 | PubTator, text mining | PubMed |
| A pharmacokinetic study on red ginseng with furosemide in equine. | Front Vet Sci | 2023 | 38076549 | PubTator, text mining | PubMed |
| The New Way to Define Key Oncogenic Drivers of Small Cell Lung Cancer. | Dev Reprod | 2023 | 38075442 | PubTator, text mining | PubMed |
| Epigenetic and Genetic Keys to Fight HPV-Related Cancers. | Cancers (Basel) | 2023 | 38067286 | PubTator, text mining | PubMed |
| Going only half the way: cell cycle exit after the G1 restriction point. | Signal Transduct Target Ther | 2023 | 38040673 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5934/papers?page=4